Adjuvant Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Memo Therapeutics Raises CHF 20M; Increases Series C to CHF 45M

Memo Therapeutics Raises CHF 20M; Increases Series C to CHF 45M
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Pureos bioventuresThomas harthHadrien bouchezPgf groupMemo therapeuticsYsios capitalKurma partnersVesalius biocapitalAdjuvant capitalVerve venturesSchroders capitalFresenius medical care venturesMemo therapeutics board

Investment in Memo Therapeutics | Company Announcement

Investegate announcements from Investment in Memo Therapeutics

John speddingPureos bioventuresSchroders capital global innovationAugustine chipunguSchroder investment managementCapital global innovation trustMemo therapeuticsYsios capitalVerve venturesFresenius medical care venturesVesalius biocapitalAdjuvant capitalMemo therapeuticNvestegate alertsK wireUk news

Memo Therapeutics increases Series C financing to CHF 45 million

Memo Therapeutics increases Series C financing to CHF 45 million
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaHadrien bouchezAmber fennellAshley tappThomas harthPureos bioventuresPgf groupYsios capitalKurma partnersMemo therapeuticsVesalius biocapitalAdjuvant capitalVerve venturesSchroders capitalFresenius medical care venturesMemo therapeutics board

Companies To Watch Antiva Biosciences

Companies To Watch Antiva Biosciences
lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.

Redwood cityUnited statesAntiva biosciencesKarl hostetlerWayne kobersteinBabson collegeUniversity of california at san diegoErnst youngExecutive editorLife science leaderBall headshotHuman papilloma virusKristine ballSan diegoCanaan partnersSofinnova investments

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million

LimmaTech Biologics Adds Additional $3 Million in Series A Second Closing Bringing Total Raised to $40 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Franz werner haasPaul wolfromAlexander siebertNicola forrestLimmatech biologicsSteve burnellStefan klotterTrophic communicationsImpact fundNovo holdingsAdjuvant capitalChief executive officerManaging directorChief financial officerTech biologicsWerner haas